ID

43210

Descripción

ODM derived from http://clinicaltrials.gov/ct2/show/NCT00334295?term=NCT00334295&rank=1

Link

http://clinicaltrials.gov/ct2/show/NCT00334295?term=NCT00334295&rank=1

Palabras clave

  1. 16/2/12 16/2/12 -
  2. 13/4/14 13/4/14 - Julian Varghese
  3. 10/8/14 10/8/14 - Martin Dugas
  4. 20/9/21 20/9/21 -
Subido en

20 de septiembre de 2021

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility NCT00334295 Metastatic Endometrial Carcinoma

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI-1
C1512693
18 Years and older
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI-1
C0001779
Female Gender
Descripción

Female Gender

Tipo de datos

boolean

Alias
UMLS CUI-1
C0086287
Histologically confirmed, recurrent or metastatic endometrial carcinoma
Descripción

Metastatic endometrial carcinoma

Tipo de datos

boolean

Alias
UMLS CUI-1
C0813148
Postmenopausal
Descripción

Postmenopausal

Tipo de datos

boolean

Alias
UMLS CUI-1
C0232970
Hormonreceptor positive tumor
Descripción

Hormonreceptor positive tumor

Tipo de datos

boolean

Alias
UMLS CUI-1
C1563119
Exclusion criteria
Descripción

Exclusion criteria

Alias
UMLS CUI-1
C0680251
Pre-treatment with Fulvestrant
Descripción

Pre-treatment with Fulvestrant

Tipo de datos

boolean

Alias
UMLS CUI-1
C1550147
Previous endocrine therapy of the endometrial carcinoma
Descripción

Previous endocrine therapy

Tipo de datos

boolean

Alias
UMLS CUI-1
C0262926
UMLS CUI-2
C0279025
Previous malignancy less than 3 years ago other than in situ carcinoma of the cervix, basal cell carcinoma or squamous carcinoma of the skin
Descripción

Previous malignancy

Tipo de datos

boolean

Alias
UMLS CUI-1
C0262926
UMLS CUI-2
C0006826

Similar models

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Inclusion Criteria
C1512693 (UMLS CUI-1)
Age
Item
18 Years and older
boolean
C0001779 (UMLS CUI-1)
Female
Item
Female Gender
boolean
C0086287 (UMLS CUI-1)
Metastatic endometrial carcinoma
Item
Histologically confirmed, recurrent or metastatic endometrial carcinoma
boolean
C0813148 (UMLS CUI-1)
Postmenopausal
Item
Postmenopausal
boolean
C0232970 (UMLS CUI-1)
Hormonreceptor positive tumor
Item
Hormonreceptor positive tumor
boolean
C1563119 (UMLS CUI-1)
Item Group
Exclusion criteria
C0680251 (UMLS CUI-1)
Pre-treatment with Fulvestrant
Item
Pre-treatment with Fulvestrant
boolean
C1550147 (UMLS CUI-1)
Previous endocrine therapy
Item
Previous endocrine therapy of the endometrial carcinoma
boolean
C0262926 (UMLS CUI-1)
C0279025 (UMLS CUI-2)
Previous malignancy
Item
Previous malignancy less than 3 years ago other than in situ carcinoma of the cervix, basal cell carcinoma or squamous carcinoma of the skin
boolean
C0262926 (UMLS CUI-1)
C0006826 (UMLS CUI-2)

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial